# Biodesix (BDSX) — News

BDSX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/bdsx/news

## Recent headlines

- [Biodesix advances tumor-informed MRD program with Bio-Rad](https://www.ainvest.com/news/biodesix-advances-tumor-informed-mrd-program-bio-rad-2609) — AInvest Wire, Sep 24, 2026
- [Biodesix advances two complementary approaches to molecular residual disease (MRD) monitoring](https://www.ainvest.com/news/biodesix-advances-complementary-approaches-molecular-residual-disease-mrd-monitoring-2609) — AInvest Wire, Sep 24, 2026
- [BioDex: for FY 2026, co sees adj EBITDA continued improvement on path to profitability](https://www.ainvest.com/news/biodex-fy-2026-sees-ebitda-continued-improvement-path-profitability-2608) — AInvest Wire, Aug 5, 2026
  Biodesix, Inc. (Nasdaq: BDSX) reported its first-quarter 2026 financial results, highlighting continued growth and operational improvements. The company generated $25.6 million in revenue for the quarter, reflecting a 42% year-over-year increase . This growth was driven by a 29% rise in diagnostic…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).